Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer

Journal of Surgical Oncology

Volumn 109, Issue 8, 2014, Pages 841-847

  Braam, Hidde J ^a   Van Oudheusden, Thijs R ^b   De Hingh, Ignace H J T ^b   Nienhuijs, Simon W ^b   Boerma, Djamila ^a   Wiezer, Marinus J ^a   Van Ramshorst, Bert ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

Author keywords

colorectal neoplasms; HIPEC; intraperitoneal chemotherapy; peritoneal neoplasms; recurrence; treatment outcome

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL ABSCESS; ADJUVANT THERAPY; ADULT; ARTICLE; BILE LEAKAGE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; COLORECTAL CANCER; COMPARATIVE EFFECTIVENESS; CYTOREDUCTIVE SURGERY; DISEASE FREE INTERVAL; DISTANT METASTASIS; FASCIA DISEASE; FEMALE; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REGIONAL METASTASIS; REOPERATION; RETROSPECTIVE STUDY; TERTIARY CARE CENTER;

COLORECTAL NEOPLASMS; HIPEC; INTRAPERITONEAL CHEMOTHERAPY; PERITONEAL NEOPLASMS; RECURRENCE; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; MALE; METASTASECTOMY; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TERTIARY CARE CENTERS;

EID: 84900528637     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23597     Document Type: Article

References (28)

1. Elias D, Quenet F, Goere D:, Current status and future directions in the treatment of peritoneal dissemination from colorectal carcinoma. Surg Oncol Clin N Am 2012; 21: 611-623.
2. Klaver YL, Lemmens VE, Nienhuijs SW, et al.: Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options. World J Gastroenterol 2012; 18: 5489-5494.
3. Chua TC, Liauw W, Chu F, et al.: Viewing metastatic colorectal cancer as a curable chronic disease. Am J Clin Oncol 2012; 35: 77-80.
4. Chua TC, Morris DL, Saxena A, et al.: Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: A multicenter study. Ann Surg Oncol 2011; 18: 1560-1567.
5. Cao C, Yan TD, Black D, et al.: A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2009; 16: 2152-2165.
6. Votanopoulos KI, Ihemelandu C, Shen P, et al.: Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy. J Am Coll Surg 2012; 215: 412-417.
7. Spiliotis J, Vaxevanidou A, Halkia E, et al.: Reoperation combining re-cytoreductive surgery and re-HIPEC for recurrent peritoneal carcinomatosis. J BUON 2012; 17: 522-525.
8. Bijelic L, Yan TD, Sugarbaker PH:, Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol 2007; 14: 2281-2288.
9. Golse N, Bakrin N, Passot G, et al.: Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: Postoperative and long-term results. J Surg Oncol 2012; 106: 197-203.
10. Klaver YL, Chua TC, Verwaal VJ, et al.: Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction. J Surg Oncol 2013; 107: 585-590.
11. Chua TC, Quinn LE, Zhao J, et al.: Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases. J Surg Oncol 2013; 108: 81-88.
12. Hagendoorn J, van Lammeren G, Boerma D, et al.: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival. Eur J Surg Oncol 2009; 35: 833-837.
13. Dindo D, Demartines N, Clavien PA:, Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
14. Shuster JJ:, Median follow-up in clinical trials. J Clin Oncol 1991; 9: 191-192.
15. Manfredi S, Bouvier AM, Lepage C, et al.: Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg 2006; 93: 1115-1122.
16. Platell CF:, Changing patterns of recurrence after treatment for colorectal cancer. Int J Colorectal Dis 2007; 22: 1223-1231.
17. Verwaal VJ, Boot H, Aleman BM, et al.: Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: Location, treatment, and outcome. Ann Surg Oncol 2004; 11: 375-379.
18. Konigsrainer I, Horvath P, Struller F, et al.: Risk factors for recurrence following complete cytoreductive surgery and HIPEC in colorectal cancer-derived peritoneal surface malignancies. Langenbecks Arch Surg 2013; 398: 745-749.
19. Cashin PH, Graf W, Nygren P, et al.: Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: Prognosis and treatment of recurrences in a cohort study. Eur J Surg Oncol 2012; 38: 509-515.
20. Kleivi K, Lind GE, Diep CB, et al.: Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses. Mol Cancer 2007; 6: 2.
21. Bruin SC, He Y, Mikolajewska-Hanclich I, et al.: Molecular alterations associated with liver metastases development in colorectal cancer patients. Br J Cancer 2011; 105: 281-287.
22. de Cuba EM, Kwakman R, van Egmond M, et al.: Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer: Future possibilities for personalised treatment by use of biomarkers. Virchows Arch 2012; 461: 231-243.
23. Harji DP, Sagar PM, Boyle K, et al.: Surgical resection of recurrent colonic cancer. Br J Surg 2013; 100: 950-958.
24. Bowne WB, Lee B, Wong WD, et al.: Operative salvage for locoregional recurrent colon cancer after curative resection: An analysis of 100 cases. Dis Colon Rectum 2005; 48: 897-909.
25. Akiyoshi T, Fujimoto Y, Konishi T, et al.: Prognostic factors for survival after salvage surgery for locoregional recurrence of colon cancer. Am J Surg 2011; 201: 726-733.
26. Goldberg RM, Fleming TR, Tangen CM, et al.: Surgery for recurrent colon cancer: Strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 1998; 129: 27-35.
27. Kaiser AM, Kang JC, Chan LS, et al.: The prognostic impact of the time interval to recurrence for the mortality in recurrent colorectal cancer. Colorectal Dis 2006; 8: 696-703.
28. Fong Y, Fortner J, Sun RL, et al.: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318, discussion 318-321.